Prognostic impact of germline and somatic variants in lymphoma-associated haemophagocytic lymphohistiocytosis.
Genetic variants in immune genes predict survival in rare lymphoma-triggered immune crises, enabling risk-based treatment intensification.
Lymphoma-associated HLH (LA-HLH) is a rare but highly lethal complication of underlying lymphoma with limited prognostic biomarkers. This British Journal of Haematology study analyzed germline and somatic variants in HLH pathway genes and found they carry independent prognostic impact, potentially enabling molecular risk stratification for more intensive monitoring or treatment escalation.
What the study was
- Study design
- retrospective_cohort
- Population
- Patients with lymphoma-associated haemophagocytic lymphohistiocytosis
- Category
- Diagnostics
- Maturity
- Exploratory
- Journal
- Br J Haematol
Why it surfaced
Addresses a rare but highly lethal complication (lymphoma-associated HLH) with no validated molecular prognostic markers; British Journal of Haematology publication with direct clinical relevance for hematologists managing aggressive lymphomas; opens molecular stratification for LA-HLH.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.